IRONWOOD PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $220.6M | $95.1M | $261.3M |
| FY2016 | — | $66.7M | $54.0M |
| FY2017 | — | $9.8M | $125.7M |
| FY2018 | — | $-196.4M | $173.2M |
| FY2019 | — | $-93.3M | $177.0M |
| FY2020 | $430.3M | $62.6M | $362.6M |
| FY2021 | $454.2M | $605.9M | $620.1M |
| FY2022 | $396.3M | $652.4M | $656.2M |
| FY2023 | — | $-346.3M | $92.2M |
| FY2024 | — | $-301.3M | $88.6M |